Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone

Affiliations

• ¹ Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ² CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Poitiers, France.
• ³ Clinical Outcomes Solutions, Tucson, Arizona, USA.
• ⁴ Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
• ⁵ Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College London, London, UK.
• ⁶ St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
• ⁷ Evangelismos Hospital, Hematology/Lymphomas and BMT Unit, Athens, Greece.
• ⁸ 1st Internal Clinic - Clinic of Hematology, General University Hospital in Prague, Prague, Czechia.
• ⁹ University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czechia.
• ¹⁰ Scientific Research Department of Chemotherapy of Hemoblastoses and Adjuvant Treatment Methods, National Cancer Institute, Rockville, Maryland, USA.
• ¹¹ Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.
• ¹² City Clinical Hospital No.4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine.
• ¹³ Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czechia.
• ¹⁴ Kings College Hospital NHS Foundation Trust, London, UK.
• ¹⁵ State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India.
• ¹⁶ Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
• ¹⁷ Group Practice for Hematology and Oncology, Dresden, Germany.
• ¹⁸ University Hospitals of Leicester NHS Trust, Leicester, UK.
• ¹⁹ Norton Cancer Institute- St. Matthews, Louisville, Kentucky, USA.
• ²⁰ Baylor University Medical Center, Dallas, Texas, USA.
• ²¹ Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
• ²² University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada.
• ²³ CHU Lille Service des Maladies du Sang, Lille, France.
• ²⁴ Policlinico S. Orsola-Malpighi, Bologna, Italy.
• ²⁵ Karyopharm Therapeutics, Newton, Massachusetts, USA.
• ²⁶ Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
• ²⁷ Medical University of Silesia, Katowice, Poland.